These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30119198)

  • 1. Emerging novel drug delivery strategies for bioactive flavonol fisetin in biomedicine.
    Mehta P; Pawar A; Mahadik K; Bothiraja C
    Biomed Pharmacother; 2018 Oct; 106():1282-1291. PubMed ID: 30119198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fisetin-loaded nanocochleates: formulation, characterisation, in vitro anticancer testing, bioavailability and biodistribution study.
    Bothiraja C; Yojana BD; Pawar AP; Shaikh KS; Thorat UH
    Expert Opin Drug Deliv; 2014 Jan; 11(1):17-29. PubMed ID: 24294925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of absolute conversion to geraldol from fisetin and pharmacokinetics in mouse.
    Jo JH; Jo JJ; Lee JM; Lee S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Dec; 1038():95-100. PubMed ID: 27810278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preparation of self-emulsifying soft capsule and its pharmacokinetic in rats for epimedium flavonoids].
    Jiang YN; Mo HY
    Zhong Yao Cai; 2010 May; 33(5):767-71. PubMed ID: 20873563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications.
    Kawabata Y; Wada K; Nakatani M; Yamada S; Onoue S
    Int J Pharm; 2011 Nov; 420(1):1-10. PubMed ID: 21884771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverse approaches for the enhancement of oral drug bioavailability.
    Fasinu P; Pillay V; Ndesendo VM; du Toit LC; Choonara YE
    Biopharm Drug Dispos; 2011 May; 32(4):185-209. PubMed ID: 21480294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibition of CYP2C8 by fisetin and its methylated metabolite, geraldol, in human liver microsomes.
    Shrestha R; Kim JH; Nam W; Lee HS; Lee JM; Lee S
    Drug Metab Pharmacokinet; 2018 Apr; 33(2):111-117. PubMed ID: 29454704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoemulsion formulation of fisetin improves bioavailability and antitumour activity in mice.
    Ragelle H; Crauste-Manciet S; Seguin J; Brossard D; Scherman D; Arnaud P; Chabot GG
    Int J Pharm; 2012 May; 427(2):452-9. PubMed ID: 22387278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prescription design and dissolution evaluation of self-emulsifying drug delivery systems of baicalin].
    Luo XQ; Yang JQ
    Zhong Yao Cai; 2010 Jul; 33(7):1157-9. PubMed ID: 21137373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Self-microemulsifying Drug Delivery System (SMEDDS) for a Novel Medicative Compound Against Depression: a Preparation and Bioavailability Study in Rats.
    Wu L; Qiao Y; Wang L; Guo J; Wang G; He W; Yin L; Zhao J
    AAPS PharmSciTech; 2015 Oct; 16(5):1051-8. PubMed ID: 25652729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of nanotechnology in pharmaceutical product development.
    Devalapally H; Chakilam A; Amiji MM
    J Pharm Sci; 2007 Oct; 96(10):2547-65. PubMed ID: 17688284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of cyclodextrins for enhancing oral bioavailability.
    Carrier RL; Miller LA; Ahmed I
    J Control Release; 2007 Nov; 123(2):78-99. PubMed ID: 17888540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies to improve oral drug bioavailability.
    Gomez-Orellana I
    Expert Opin Drug Deliv; 2005 May; 2(3):419-33. PubMed ID: 16296764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permeation enhancer strategies in transdermal drug delivery.
    Marwah H; Garg T; Goyal AK; Rath G
    Drug Deliv; 2016; 23(2):564-78. PubMed ID: 25006687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug delivery system based on chronobiology--A review.
    Mandal AS; Biswas N; Karim KM; Guha A; Chatterjee S; Behera M; Kuotsu K
    J Control Release; 2010 Nov; 147(3):314-25. PubMed ID: 20691738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of Nanocarriers as Drug Delivery Vehicles for Active Phytoconstituents.
    Ng PQ; Ling LSC; Chellian J; Madheswaran T; Panneerselvam J; Kunnath AP; Gupta G; Satija S; Mehta M; Hansbro PM; Collet T; Dua K; Chellappan DK
    Curr Pharm Des; 2020; 26(36):4580-4590. PubMed ID: 32520681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel drug-phospholipid complex loaded micelle for baohuoside I enhanced oral absorption: in vivo and in vivo evaluations.
    Jin X; Zhang ZH; Sun E; Tan XB; Zhu FX; Jia XB
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1421-30. PubMed ID: 23057574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atazanavir-loaded Eudragit RL 100 nanoparticles to improve oral bioavailability: optimization and in vitro/in vivo appraisal.
    Singh G; Pai RS
    Drug Deliv; 2016; 23(2):532-9. PubMed ID: 24963752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.